HDV Treatment

CE / CME

Hepatitis Delta Treatment: Where We Are and Where We Are Headed

Physicians: Maximum of 0.25 AMA PRA Category 1 Credit

Nurses: 0.25 Nursing contact hour

Released: March 03, 2022

Expiration: March 02, 2023

Nancy Reau
Nancy Reau, MD
Stefan Zeuzem
Stefan Zeuzem, MD

Activity

Progress
1
Course Completed

Treatment options for hepatitis delta virus (HDV) are lacking, but many exciting agents are under investigation. Hear Drs Nancy Reau and Stefan Zeuzem discuss their thoughts on up-and-coming agents for treating HDV, and explore what questions need answering to most effectively use currently available and emerging therapies, which include:

  • Bulevirtide
  • Interferon λ
  • Lonafarnib